Stryker, Boston Scientific tie-up could create ‘higher growth Medtronic’

Analysts are eagerly digging into the news that Stryker (NYSE:SYK) put in a takeover bid with Boston Scientific (NYSE:BSX), though many were surprised by the news and are unsure of the obvious strategic value of the acquisition.

News of the deal, which both companies have officially responded to with statemens of “no comment,” emerged yesterday at the Wall Street Journal.

The merger could create a “higher growth Medtronic,” according to Evercore’s Vijay Kumar, adding approximately 2% to Stryker’s expected 2019 earnings per share and up to 6% by next year, SeekingAlpha reported.

Get the full story on our sister site MassDevice.

Only a Few More Days to Register for the most anticipated conference of the winter! DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry. Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry. REGISTER NOW Use code LASTCHANCE to save an additional 20%.